FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/06/019948 [Registered on: 28/06/2019] Trial Registered Prospectively
Last Modified On: 24/07/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Yoga & Naturopathy
Preventive
Behavioral
Other (Specify) [Cardiac Rehabilitation]  
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Effect of cardiac rehabilitation in patients undergone myocardial infarction and percutaneous coronary intervention 
Scientific Title of Study   A Randomized Controlled Trial of Cardiac Rehabilitation in Myocardial Infarction Patients with Percutaneous Coronary Intervention 
Trial Acronym  MY-CARE 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Kunjan 
Designation  PhD Student 
Affiliation  PGIMER 
Address  Department of Community Medicine and School of Public Health, PGIMER

Chandigarh
CHANDIGARH
160012
India 
Phone  9459856115  
Fax    
Email  dr.kunjan2human@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr JS Thakur 
Designation  Professor 
Affiliation  PGIMER 
Address  Department of Community Medicine and School of Public Health, PGIMER

Chandigarh
CHANDIGARH
160012
India 
Phone  9463602173  
Fax    
Email  jsthakur64@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr JS Thakur 
Designation  Professor 
Affiliation  PGIMER 
Address  Department of Community Medicine and School of Public Health, PGIMER

Chandigarh
CHANDIGARH
160012
India 
Phone  9463602173  
Fax    
Email  jsthakur64@gmail.com  
 
Source of Monetary or Material Support  
Fellowship from Postgraduate Institute of Medical Education and Research, Chandigarh 
 
Primary Sponsor  
Name  Dr JS Thakur 
Address  Department of Community Medicine and School of Public Health, PGIMER 
Type of Sponsor  Other [Professor of Community Medicine] 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Kunjan  PGIMER  Advanced Cardiac Centre (Department of Cardiology) OPD, Department of Community Medicine and School of Public Health
Chandigarh
CHANDIGARH 
9459856115

dr.kunjan2human@gmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
Institute Ethic Committee (Intramural)  Approved 
Institute Ethics Committee(Intramural)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied
Modification(s)  
Health Type  Condition 
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Cardiac rehabilitation  Adapted phase II and phase III of cardiac rehabilitation program with components of physical activity, education on coronary artery disease and heart-healthy living  
Comparator Agent  Routine care  Participants will not receive any supervised physical activity training. Participants will receive routine care for myocardial infarction after undergoing percutaneous coronary intervention according to current guidelines.  
 
Inclusion Criteria
Modification(s)  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1. 18-80 years of age
2. Patients diagnosed with myocardial infarction who have undergone percutaneous coronary intervention and are not at risk due to other comorbidities.
3. Willing to give informed consent
4. Patients with New York Heart Association, NYHA functional class I, II & III symptoms
 
 
ExclusionCriteria 
Details  1. Participants with medical conditions which could put them at risk during physical activity testing or training e.g., angina or conditions that could limit the ability of participants to exercise e.g., severe orthopaedic or neurologic impairments 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking
Modification(s)  
Open Label 
Primary Outcome  
Outcome  TimePoints 
Physical activity
Functional capacity
Knowledge related to coronary artery disease
Depression scores
Medication adherence 
6 months 
 
Secondary Outcome  
Outcome  TimePoints 
Health related quality of life.
Anthropometric measures: Body Mass Index (BMI), Waist circumference.
Risk profile and biochemical measures: BP(Blood Pressure), LDL(Low Density Lipoprotein), HDL(High Density Lipoprotein), Fasting glucose, HbA1c
Cost effective implementation of cardiac rehabilitation model
All-cause mortality 
6 months 
 
Target Sample Size   Total Sample Size="382"
Sample Size from India="382" 
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="382" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   02/07/2019 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary
Modification(s)  

This study is a two-group randomized controlled trial with participants who have experienced myocardial infarction and who have already undergone percutaneous coronary intervention as well. At the end of a period of 6 months, the primary outcomes will be measured with respect to physical activity, functional capacity, knowledge related to coronary artery disease, depression scores, medication adherence. Secondary outcome measures will be health related quality of life; anthropometric measures i.e., body mass index, waist circumference; risk profile; biochemical measures i.e., blood pressure, low density lipoprotein, high density lipoprotein, fasting glucose, HbA1c; cost effective implementation of cardiac rehabilitation model and all-cause mortality.

 

 

 

 
Close